Focal laser treatment in addition to chemotherapy for retinoblastoma
Author:
Affiliation:
1. Moorfields Eye Hospital NHS Foundation Trust; 162 City Road London UK EC1V 2PD
2. Royal London Hospital, Barts Health NHS Trust; Whitechapel Road London UK E1 1BB
Publisher
Wiley
Subject
Pharmacology (medical)
Reference71 articles.
1. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma;Friedman;Journal of Clinical Oncology,2000
2. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intra ocular retinoblastoma: preliminary results;Levy;British Journal of Ophthalmology,1998
3. Conservative treatment of intraocular retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy;Aerts;Journal of Clinical Oncology,2013
4. Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy;Lumbroso-Le Rouic;Eye,2016
5. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma;Shields;Ophthalmology,1997
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy;RSC Medicinal Chemistry;2024
2. Evidence in Focus: The Sparse Landscape of Randomized Trials on Retinoblastoma Treatment;Ocular Oncology and Pathology;2024
3. Lipid-nanoparticles-based co-delivery of black phosphorus quantum dots and melphalan by photothermal therapy combined with chemotherapy for retinoblastoma;Polymer Testing;2023-12
4. Conservative treatment using laser diode and systemic chemotherapy for early‐stage bilateral retinoblastoma: A 14‐year prospective cohort study;Cancer Reports;2023-10-17
5. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses;Pathology - Research and Practice;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3